Company Filing History:
Years Active: 2008
Title: Giselle Pentón Roll: Innovator in Genetic Engineering
Introduction
Giselle Pentón Roll is a notable inventor based in La Habana, Cuba. He has made significant contributions to the field of genetic engineering and biotechnology. His work focuses on developing innovative solutions for various medical challenges.
Latest Patents
Giselle Pentón Roll holds a patent for a chimeric antagonist known as anth1. This recombinant chimeric antagonist is formed by a 60 amino acid fragment of the N-terminal region of human interleukin 2 (IL-2) fused to the N-terminal of the extracellular region of the alpha subunit of the gamma interferon (IFN-γ) receptor. In vitro, this protein exhibits T cell growth-stimulating activity while inhibiting the growth-stimulating activity of IL-2 in T cells. Additionally, it inhibits the induction of HLA-DR by IFN-γ and the antiproliferative activity of IFN-γ. This invention has potential applications in medicine for treating various pathologies, including autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome, and atherosclerosis.
Career Highlights
Giselle Pentón Roll is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Giselle has collaborated with notable colleagues, including Iraldo Bello Rivero and Yeny Torres Ruiz. Their combined efforts contribute to the advancement of genetic engineering and biotechnology.
Conclusion
Giselle Pentón Roll is a pioneering inventor whose work in genetic engineering has the potential to revolutionize medical treatments. His innovative patent and collaborations highlight his commitment to addressing significant health challenges.